AIxplorerBio's Multi-target Small Molecule Drug Design Platform (AIxMTDD) unveiled at the China AI for Pharma R&D Conference (CAPR2023)

Source:索智生物 Time:2023-05-29

The China AI for Pharma R&D Conference (CAPR2023) was held in Shanghai on May 25-26. The conference focused on the latest progress in AI-enabled drug research and development in recent years. During the event, AIxplorerBio demonstrated its multi-target small molecule drug design platform for the first time. The company also adetailed the main technologies of the platform and its application in the company's dual-target drug research and development.